Rankings
▼
Calendar
SCYX Q1 2025 Earnings — SCYNEXIS, Inc. Revenue & Financial Results | Market Cap Arena
SCYX
SCYNEXIS, Inc.
$38M
Q1 2025 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$257,000
-81.3% YoY
Gross Profit
$257,000
100.0% margin
Operating Income
-$9M
-3350.2% margin
Net Income
-$5M
-2097.7% margin
EPS (Diluted)
$-0.11
QoQ Revenue Growth
-73.7%
Cash Flow
Operating Cash Flow
-$7M
Free Cash Flow
-$7M
Stock-Based Comp.
$819,000
Balance Sheet
Total Assets
$68M
Total Liabilities
$17M
Stockholders' Equity
$51M
Cash & Equivalents
$7M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$257,000
$1M
-81.3%
Gross Profit
$257,000
$1M
-81.3%
Operating Income
-$9M
-$10M
+9.4%
Net Income
-$5M
$411,000
-1411.7%
Revenue Segments
License and Service
$257,000
100%
← FY 2025
All Quarters
Q2 2025 →